Zimmer posts Q3 earnings above expectations, narrows guidance

October 23, 2014 by Brad Perriello

Zimmer Holdings says its 3rd-quarter earnings beat expectations and narrows its sales and earnings guidance for the rest of the year.

Zimmer‘s (NYSE:ZMH) 3rd-quarter earnings came in ahead of expectations on strong performances from its core knee and hip implant businesses.

Zimmer posted profits of $165.5 million, or 96¢ per share, on sales of $1.11 billion during the 3 months ended Sept. 30, for bottom-line growth of 7.2% on sales growth of 3.0% compared with Q3 2013.

Adjusted to exclude 1-time items, earnings per share were $1.35, a full 5¢ above expectations on Wall Street.

Sales of Zimmer’s knee implants rose 6% on a constant currency basis, led by 10% growth in Europe. Hip implant sales were up 3% worldwide but flat in the U.S., the Warsaw, Ind.-based company said.


Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button